Cargando…
Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurr...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349572/ https://www.ncbi.nlm.nih.gov/pubmed/22443372 http://dx.doi.org/10.1186/1471-230X-12-24 |
_version_ | 1782232526581923840 |
---|---|
author | Laubert, Tilman Habermann, Jens K Hemmelmann, Claudia Kleemann, Markus Oevermann, Elisabeth Bouchard, Ralf Hildebrand, Philipp Jungbluth, Thomas Bürk, Conny Esnaashari, Hamed Schlöricke, Erik Hoffmann, Martin Ziegler, Andreas Bruch, Hans-Peter Roblick, Uwe J |
author_facet | Laubert, Tilman Habermann, Jens K Hemmelmann, Claudia Kleemann, Markus Oevermann, Elisabeth Bouchard, Ralf Hildebrand, Philipp Jungbluth, Thomas Bürk, Conny Esnaashari, Hamed Schlöricke, Erik Hoffmann, Martin Ziegler, Andreas Bruch, Hans-Peter Roblick, Uwe J |
author_sort | Laubert, Tilman |
collection | PubMed |
description | BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients. METHODS: 1,395 patients underwent surgery exclusively for colon cancer at the University of Lübeck between 01/1993 and 12/2008. The following exclusion criteria were applied: synchronous metastasis, R1-resection, prior/synchronous second carcinoma, age < 50 years, positive family history, inflammatory bowel disease, FAP, HNPCC, and follow-up < 5 years. The remaining 421 patients were divided into groups with (TM+, n = 75) or without (TM-, n = 346) the occurrence of metastasis throughout a 5-year follow-up. RESULTS: Five-year survival rates for TM + and TM- were 21% and 73%, respectively (p < 0.0001). Survival rates differed significantly for N0 vs. N2, grading 2 vs. 3, UICC-I vs. -II and UICC-I vs. -III (p < 0.05). Regression analysis revealed higher age upon diagnosis, increasing N- and increasing T-category to significantly impact on recurrence free survival while increasing N-and T-category were significant parameters for the risk to develop metastases within 5-years after surgery (HR 1.97 and 1.78; p < 0.0001). CONCLUSIONS: Besides a higher T-category, a positive N-stage independently implies a higher probability to develop distant metastases and correlates with poor survival. Our data thus show a prognostic relevance of lymphadenectomy which should therefore be retained until conclusive studies suggest the unimportance of lmyphadenectomy. |
format | Online Article Text |
id | pubmed-3349572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33495722012-05-11 Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas Laubert, Tilman Habermann, Jens K Hemmelmann, Claudia Kleemann, Markus Oevermann, Elisabeth Bouchard, Ralf Hildebrand, Philipp Jungbluth, Thomas Bürk, Conny Esnaashari, Hamed Schlöricke, Erik Hoffmann, Martin Ziegler, Andreas Bruch, Hans-Peter Roblick, Uwe J BMC Gastroenterol Research Article BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients. METHODS: 1,395 patients underwent surgery exclusively for colon cancer at the University of Lübeck between 01/1993 and 12/2008. The following exclusion criteria were applied: synchronous metastasis, R1-resection, prior/synchronous second carcinoma, age < 50 years, positive family history, inflammatory bowel disease, FAP, HNPCC, and follow-up < 5 years. The remaining 421 patients were divided into groups with (TM+, n = 75) or without (TM-, n = 346) the occurrence of metastasis throughout a 5-year follow-up. RESULTS: Five-year survival rates for TM + and TM- were 21% and 73%, respectively (p < 0.0001). Survival rates differed significantly for N0 vs. N2, grading 2 vs. 3, UICC-I vs. -II and UICC-I vs. -III (p < 0.05). Regression analysis revealed higher age upon diagnosis, increasing N- and increasing T-category to significantly impact on recurrence free survival while increasing N-and T-category were significant parameters for the risk to develop metastases within 5-years after surgery (HR 1.97 and 1.78; p < 0.0001). CONCLUSIONS: Besides a higher T-category, a positive N-stage independently implies a higher probability to develop distant metastases and correlates with poor survival. Our data thus show a prognostic relevance of lymphadenectomy which should therefore be retained until conclusive studies suggest the unimportance of lmyphadenectomy. BioMed Central 2012-03-23 /pmc/articles/PMC3349572/ /pubmed/22443372 http://dx.doi.org/10.1186/1471-230X-12-24 Text en Copyright ©2012 Laubert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Laubert, Tilman Habermann, Jens K Hemmelmann, Claudia Kleemann, Markus Oevermann, Elisabeth Bouchard, Ralf Hildebrand, Philipp Jungbluth, Thomas Bürk, Conny Esnaashari, Hamed Schlöricke, Erik Hoffmann, Martin Ziegler, Andreas Bruch, Hans-Peter Roblick, Uwe J Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title_full | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title_fullStr | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title_full_unstemmed | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title_short | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
title_sort | metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349572/ https://www.ncbi.nlm.nih.gov/pubmed/22443372 http://dx.doi.org/10.1186/1471-230X-12-24 |
work_keys_str_mv | AT lauberttilman metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT habermannjensk metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT hemmelmannclaudia metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT kleemannmarkus metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT oevermannelisabeth metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT bouchardralf metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT hildebrandphilipp metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT jungbluththomas metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT burkconny metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT esnaasharihamed metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT schlorickeerik metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT hoffmannmartin metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT zieglerandreas metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT bruchhanspeter metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas AT roblickuwej metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas |